BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34954232)

  • 1. Suppression of stemness and enhancement of chemosensibility in the resistant melanoma were induced by Astragalus polysaccharide through PD-L1 downregulation.
    Gong Q; Yu H; Ding G; Ma J; Wang Y; Cheng X
    Eur J Pharmacol; 2022 Feb; 916():174726. PubMed ID: 34954232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo.
    Sha X; Xu X; Liao S; Chen H; Rui W
    Exp Cell Res; 2022 Jan; 410(1):112948. PubMed ID: 34826423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragalus polysaccharide exerts anti-Parkinson via activating the PI3K/AKT/mTOR pathway to increase cellular autophagy level in vitro.
    Tan Y; Yin L; Sun Z; Shao S; Chen W; Man X; Du Y; Chen Y
    Int J Biol Macromol; 2020 Jun; 153():349-356. PubMed ID: 32112840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
    Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L
    EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragalus membranaceus polysaccharides potentiate the growth-inhibitory activity of immune checkpoint inhibitors against pulmonary metastatic melanoma in mice.
    Hwang J; Zhang W; Dhananjay Y; An EK; Kwak M; You S; Lee PC; Jin JO
    Int J Biol Macromol; 2021 Jul; 182():1292-1300. PubMed ID: 34000307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect and the mechanism of Astragalus polysaccharide combined with cisplatin on growth of inplanted Lewis lung carcinoma in mice].
    Zhuang M; Liu D; Chen Y; Ming H; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):503-507. PubMed ID: 28395722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragalus polysaccharide ameliorates lipopolysaccharide-induced cell injury in ATDC5 cells via miR-92a/KLF4 mediation.
    Fan L; Li M; Cao FY; Zeng ZW; Li XB; Ma C; Ru JT; Wu XJ
    Biomed Pharmacother; 2019 Oct; 118():109180. PubMed ID: 31302422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice.
    Ding G; Gong Q; Ma J; Liu X; Wang Y; Cheng X
    Cancer Sci; 2021 Oct; 112(10):4050-4063. PubMed ID: 34289209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle.
    Liu M; Wu K; Mao X; Wu Y; Ouyang J
    J Ethnopharmacol; 2010 Jan; 127(1):32-7. PubMed ID: 19800959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extracts of
    Chang HL; Kuo YH; Wu LH; Chang CM; Cheng KJ; Tyan YC; Lee CH
    Int J Med Sci; 2020; 17(7):939-945. PubMed ID: 32308547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.
    Zhang P; Ma Y; Lv C; Huang M; Li M; Dong B; Liu X; An G; Zhang W; Zhang J; Zhang L; Zhang S; Yang Y
    Cancer Sci; 2016 Nov; 107(11):1563-1571. PubMed ID: 27581532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of astragalus polysaccharide on apoptosis of myocardial microvascular endothelial cells in rats undergoing hypoxia/reoxygenation by mediation of the PI3K/Akt/eNOS signaling pathway.
    Zhou Q; Meng G; Teng F; Sun Q; Zhang Y
    J Cell Biochem; 2018 Jan; 119(1):806-816. PubMed ID: 28657671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways.
    Cao Y; Ruan Y; Shen T; Huang X; Li M; Yu W; Zhu Y; Man Y; Wang S; Li J
    Oxid Med Cell Longev; 2014; 2014():674219. PubMed ID: 25386226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Astragalus polysaccharide combined with cisplatin inhibits growth of recurrent tumor and down-regulats the expression of CD44, CD62P and osteopontin in tumor tissues in mice bearing Lewis lung cancer].
    Liu D; Li Y; Wang X; Wang Y; Ma Y; Chen Y; Ming H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Dec; 34(12):1105-1110. PubMed ID: 30626477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remyelination is enhanced by Astragalus polysaccharides through inducing the differentiation of oligodendrocytes from neural stem cells in cuprizone model of demyelination.
    Ye N; Cruz J; Peng X; Ma J; Zhang A; Cheng X
    Brain Res; 2021 Jul; 1763():147459. PubMed ID: 33794147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic sulfide reverses cisplatin resistance in non-small cell lung cancer in vitro and in vivo through targeting PD-L1.
    Tian W; Sun Y; Cheng Y; Ma X; Du W; Shi W; Guo Q
    Thorac Cancer; 2021 Oct; 12(19):2551-2563. PubMed ID: 34469060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragalus polysaccharide inhibits breast cancer cell migration and invasion by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
    Yang S; Sun S; Xu W; Yu B; Wang G; Wang H
    Mol Med Rep; 2020 Apr; 21(4):1819-1832. PubMed ID: 32319619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases.
    Zhou Z; Meng M; Ni H
    Med Sci Monit; 2017 Jan; 23():462-469. PubMed ID: 28124680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.
    Chang X; Lu K; Wang L; Lv M; Fu W
    Biosci Trends; 2018 May; 12(2):149-156. PubMed ID: 29607874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression.
    Wu L; Cai S; Deng Y; Zhang Z; Zhou X; Su Y; Xu D
    Int Immunopharmacol; 2021 May; 94():107443. PubMed ID: 33581579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.